Shares of GE HealthCare Technologies Inc. GEHC slipped 2.10% to $83.79 Wednesday, on what proved to be an all-around mixed ...

Fintel reports that on March 11, 2025, Goldman Sachs upgraded their outlook for GE HealthCare Technologies (NasdaqGS:GEHC) ...

The Goldman Sachs Group upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC – Free Report) from a neutral rating to a buy rating in a research note published on Tuesday morning, MarketBeat ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $104.0, a high estimate of $110.00, and a low estimate of $100.00. Observing a 9.76 ...

Goldman Sachs upgraded GE HealthCare (GEHC) to Buy from Neutral with a price target of $100, up from $85. The firm’s confidence in the outlook ...

Johnson & Johnson MedTech said Wednesday its Monarch Quest robotic platform received clearance from the Food and Drug ...

Learn more about whether GE HealthCare Technologies Inc. or Insulet Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China ...

Siemens unveiled the two photon-counting CTs in December. GE HealthCare and Philips Healthcare are developing their own ...

Shares of GE HealthCare Technologies Inc. GEHC advanced 1.37% to $86.58 Friday, on what proved to be an all-around favorable ...

The medical equipment manufacturer has tapped a longtime leader in China's health care environment to ease the transition ...